
18/07/2025
🧿 Can fewer injections still protect your vision?
Aflibercept is a treatment for neovascular age-related macular degeneration (AMD) — a major cause of blindness in older adults.
🔍 A Cochrane Review compared aflibercept with ranibizumab:
✅ Both drugs improved vision equally well
✅ Few serious side effects were reported
✅ Aflibercept may require fewer injections
💬 What it means: Aflibercept is as effective as current treatments, and possibly more convenient for patients.
👁 Backed by high-quality evidence for vision outcomes, though more research is needed to fully understand side effects.
AUTHORS: Salman Sarwar, Elizabeth Clearfield, Mohamed Kamel Soliman, Mohammad Ali Sadiq, Andrew J Baldwin, Mostafa Hanout, Aniruddha Agarwal, Yasir J Sepah, Diana V Do, Quan D**g Nguyen
READ MORE: https://doi.org/10.1002/14651858.CD011346.pub2